Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
There are no standards requiring radiologists to report on the presence of BACs, even though up to half of referring providers have indicated they would prefer to be made aware of the finding.
Despite the great progress that has been made toward the clinical implementation of AI, new data caution against trusting the technology as a single reader in certain settings.
The ACR hopes these changes, including the addition of diagnostic performance feedback, will help reduce the number of patients with incidental nodules lost to follow-up each year.
CMS Inc. and Siemens Medical Solutions have inked a three-year sales and development agreement for treatment planning software for radiation oncology under which CMS will become a preferred provider of treatment planning software to Siemens.
Yoqneam, Israel-based Given Imaging has received FDA marketing clearance for its new Given Diagnostic System, including the PillCam ESO video capsule for imaging the esophagus.
NEC-Mitsubishi Electronics Display of America Inc. is now shipping the 3 megapixel (MP) NEC MultiSync MD21GS-3MP grayscale monitor and in November will start shipping the 2MP NEC MultiSync MD21GS-2MP grayscale monitor.
The American Healthcare Radiology Administrators is calling for presentations for its 2005 Electronic Imaging Conference, April 21 - 23, at the Grand Hyatt Hotel in Tampa, Fla.
Barco announced this week that all of its divisions - Medical Imaging Systems, Avionics, Traffic Management and Defense & Security - have moved to a new location.
Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.
The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.
